Short-term B-cell Depletion in Relapsing Multiple Sclerosis

NCT03853746 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Ocrelizumab

Sponsor

Johns Hopkins University

Collaborators

[object Object]